BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heimpel H, Anselstetter V, Chrobak L, Denecke J, Einsiedler B, Gallmeier K, Griesshammer A, Marquardt T, Janka-Schaub G, Kron M. Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. Blood. 2003;102:4576-4581. [PMID: 12933587 DOI: 10.1182/blood-2003-02-0613] [Cited by in Crossref: 72] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Marwaha RK, Bansal D, Trehan A, Garewal G. Interferon therapy in congenital dyserythropoietic anemia type I/II. Pediatr Hematol Oncol. 2005;22:133-138. [PMID: 15804998 DOI: 10.1080/08880010590907221] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
2 Zaninoni A, Fermo E, Vercellati C, Marcello AP, Barcellini W, Bianchi P. Congenital Hemolytic Anemias: Is There a Role for the Immune System? Front Immunol 2020;11:1309. [PMID: 32655575 DOI: 10.3389/fimmu.2020.01309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
3 King M, Bruce LJ, Dhermy D. Hemolytic Anemias Associated with Disorders of Erythrocyte Membrane and Cytoskeleton Proteins. In: Kottke-marchant K, Davis BH, editors. Laboratory Hematology Practice. Oxford: Wiley-Blackwell; 2012. pp. 602-14. [DOI: 10.1002/9781444398595.ch46] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Carden MA, Barman A, Massey G. Pulmonary alveolar proteinosis in association with congenital dyserythropoietic anemia: a case report. Case Rep Pediatr 2012;2012:624740. [PMID: 22953144 DOI: 10.1155/2012/624740] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Denecke J, Kranz C, Nimtz M, Conradt HS, Brune T, Heimpel H, Marquardt T. Characterization of the N-glycosylation phenotype of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (CDA II/HEMPAS). Glycoconj J 2008;25:375-82. [PMID: 18166993 DOI: 10.1007/s10719-007-9089-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
6 King MJ, Garçon L, Hoyer JD, Iolascon A, Picard V, Stewart G, Bianchi P, Lee SH, Zanella A; International Council for Standardization in Haematology. ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders. Int J Lab Hematol 2015;37:304-25. [PMID: 25790109 DOI: 10.1111/ijlh.12335] [Cited by in Crossref: 78] [Cited by in F6Publishing: 58] [Article Influence: 13.0] [Reference Citation Analysis]
7 Modi G, Shah S, Madabhavi I, Panchal H, Patel A, Uparkar U, Anand A, Parikh S, Patel K, Shah K, Revannasiddaiah S. Successful Allogeneic Hematopoietic Stem Cell Transplantation of a Patient Suffering from Type II Congenital Dyserythropoietic Anemia A Rare Case Report from Western India. Case Rep Hematol 2015;2015:792485. [PMID: 25692053 DOI: 10.1155/2015/792485] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
8 Chen S, Guo Z, Ye Y, Yang S, Huang G. Compound heterozygosity for two novel mutations of the SEC23B gene in congenital dyserythropoietic anemia type II. Int J Hematol 2021;114:390-4. [PMID: 33914262 DOI: 10.1007/s12185-021-03155-1] [Reference Citation Analysis]
9 Iolascon A, Andolfo I, Barcellini W, Corcione F, Garçon L, De Franceschi L, Pignata C, Graziadei G, Pospisilova D, Rees DC, de Montalembert M, Rivella S, Gambale A, Russo R, Ribeiro L, Vives-Corrons J, Martinez PA, Kattamis A, Gulbis B, Cappellini MD, Roberts I, Tamary H; Working Study Group on Red Cells and Iron of the EHA. Recommendations regarding splenectomy in hereditary hemolytic anemias. Haematologica 2017;102:1304-13. [PMID: 28550188 DOI: 10.3324/haematol.2016.161166] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 14.8] [Reference Citation Analysis]
10 de-la-Iglesia-Iñigo S, Moreno-Carralero MI, Lemes-Castellano A, Molero-Labarta T, Méndez M, Morán-Jiménez MJ. A case of congenital dyserythropoietic anemia type IV. Clin Case Rep 2017;5:248-52. [PMID: 28265383 DOI: 10.1002/ccr3.825] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
11 Bianchi P, Fermo E, Vercellati C, Boschetti C, Barcellini W, Iurlo A, Marcello AP, Righetti PG, Zanella A. Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene. Hum Mutat 2009;30:1292-8. [DOI: 10.1002/humu.21077] [Cited by in Crossref: 121] [Cited by in F6Publishing: 98] [Article Influence: 10.1] [Reference Citation Analysis]
12 Schwarz K, Iolascon A, Verissimo F, Trede NS, Horsley W, Chen W, Paw BH, Hopfner K, Holzmann K, Russo R, Esposito MR, Spano D, De Falco L, Heinrich K, Joggerst B, Rojewski MT, Perrotta S, Denecke J, Pannicke U, Delaunay J, Pepperkok R, Heimpel H. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet 2009;41:936-40. [DOI: 10.1038/ng.405] [Cited by in Crossref: 188] [Cited by in F6Publishing: 157] [Article Influence: 15.7] [Reference Citation Analysis]
13 Heimpel H, Kellermann K, Neuschwander N, Högel J, Schwarz K. The morphological diagnosis of congenital dyserythropoietic anemia: results of a quantitative analysis of peripheral blood and bone marrow cells. Haematologica 2010;95:1034-6. [PMID: 20421275 DOI: 10.3324/haematol.2009.014563] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
14 Russo R, Esposito MR, Iolascon A. Inherited hematological disorders due to defects in coat protein (COP)II complex. Am J Hematol 2013;88:135-40. [PMID: 22764119 DOI: 10.1002/ajh.23292] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
15 Casanovas G, Swinkels DW, Altamura S, Schwarz K, Laarakkers CM, Gross HJ, Wiesneth M, Heimpel H, Muckenthaler MU. Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II. J Mol Med (Berl) 2011;89:811-6. [PMID: 21475976 DOI: 10.1007/s00109-011-0751-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
16 Oudit GY, Trivieri MG, Khaper N, Liu PP, Backx PH. Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy. J Mol Med (Berl). 2006;84:349-364. [PMID: 16604332 DOI: 10.1007/s00109-005-0029-x] [Cited by in Crossref: 127] [Cited by in F6Publishing: 116] [Article Influence: 8.5] [Reference Citation Analysis]
17 Barton JC, Acton RT, Leiendecker-Foster C, Lovato L, Adams PC, Eckfeldt JH, McLaren CE, Reiss JA, McLaren GD, Reboussin DM, Gordeuk VR, Speechley MR, Press RD, Dawkins FW; Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening. Am J Hematol 2008;83:126-32. [PMID: 17726683 DOI: 10.1002/ajh.21053] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
18 Aydin Koker S, Karapinar TH, Oymak Y, Bianchi P, Fermo E, Gozmen S, Vergin C. Identification of a Novel Mutation in the SEC23B Gene Associated With Congenital Dyserythropoietic Anemia Type II Through the Use of Next-generation Sequencing Panel in an Undiagnosed Case of Nonimmune Hereditary Hemolytic Anemia. J Pediatr Hematol Oncol 2018;40:e421-3. [PMID: 29846281 DOI: 10.1097/MPH.0000000000001207] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
19 Zhao N, Enns CA. N-linked glycosylation is required for transferrin-induced stabilization of transferrin receptor 2, but not for transferrin binding or trafficking to the cell surface. Biochemistry 2013;52:3310-9. [PMID: 23556518 DOI: 10.1021/bi4000063] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
20 Schmidt K, Stephens DJ. Cargo loading at the ER. Mol Membr Biol 2010;27:398-411. [PMID: 21142873 DOI: 10.3109/09687688.2010.506203] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
21 Niss O, Lorsbach RB, Berger M, Chonat S, McLemore M, Buchbinder D, McCavit T, Shaffer LG, Simpson J, Schwartz JH, Meznarich J, Emberesh M, Seu KG, Zhang W, Kalfa TA; CDAR consortium. Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR). Blood Cells Mol Dis 2021;87:102534. [PMID: 33401150 DOI: 10.1016/j.bcmd.2020.102534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Achcar F, Camadro JM, Mestivier D. A Boolean probabilistic model of metabolic adaptation to oxygen in relation to iron homeostasis and oxidative stress. BMC Syst Biol 2011;5:51. [PMID: 21489274 DOI: 10.1186/1752-0509-5-51] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
23 Rice HE, Crary SE, Langer JC, Kemper AR. Comparative Effectiveness of Different Types of Splenectomy for Children with Congenital Hemolytic Anemias. The Journal of Pediatrics 2012;160:684-689.e13. [DOI: 10.1016/j.jpeds.2011.09.030] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
24 Roy NBA, Babbs C. The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I. Br J Haematol 2019;185:436-49. [PMID: 30836435 DOI: 10.1111/bjh.15817] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
25 Heimpel H, Dührsen U, Hofbauer P, Rigamonti-wermlinger V, Kreuser E, Schwarz K, Solenthaler M, Pauls S. Bulky extramedullary hematopoiesis is not a rare complication of congenital dyserythropoietic anemia. Ann Hematol 2009;88:937-41. [DOI: 10.1007/s00277-009-0735-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
26 Punzo F, Bertoli-Avella AM, Scianguetta S, Della Ragione F, Casale M, Ronzoni L, Cappellini MD, Forni G, Oostra BA, Perrotta S. Congenital dyserythropoietic anemia type II: molecular analysis and expression of the SEC23B gene. Orphanet J Rare Dis 2011;6:89. [PMID: 22208203 DOI: 10.1186/1750-1172-6-89] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
27 Wickramasinghe SN, Wood WG. Advances in the understanding of the congenital dyserythropoietic anaemias. Br J Haematol 2005;131:431-46. [DOI: 10.1111/j.1365-2141.2005.05757.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 65] [Article Influence: 5.4] [Reference Citation Analysis]
28 Pellegrin S, Haydn-Smith KL, Hampton-O'Neil LA, Hawley BR, Heesom KJ, Fermo E, Bianchi P, Toye AM. Transduction with BBF2H7/CREB3L2 upregulates SEC23A protein in erythroblasts and partially corrects the hypo-glycosylation phenotype associated with CDAII. Br J Haematol 2019;184:876-81. [PMID: 29536501 DOI: 10.1111/bjh.15189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
29 Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet. 2008;372:1411-1426. [PMID: 18940465 DOI: 10.1016/s0140-6736(08)61588-3] [Cited by in Crossref: 324] [Cited by in F6Publishing: 125] [Article Influence: 24.9] [Reference Citation Analysis]
30 Moreno-Carralero MI, Horta-Herrera S, Morado-Arias M, Ricard-Andrés MP, Lemes-Castellano A, Abio-Calvete M, Cedena-Romero MT, González-Fernández FA, Llorente-González L, Periago-Peralta AM, de-la-Iglesia-Íñigo S, Méndez M, Morán-Jiménez MJ. Clinical and genetic features of congenital dyserythropoietic anemia (CDA). Eur J Haematol 2018;101:368-78. [PMID: 29901818 DOI: 10.1111/ejh.13112] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
31 Denecke J, Marquardt T. Congenital dyserythropoietic anemia type II (CDAII/HEMPAS): where are we now? Biochim Biophys Acta 2009;1792:915-20. [PMID: 19150496 DOI: 10.1016/j.bbadis.2008.12.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
32 Iolascon A, Esposito MR, Russo R. Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach. Haematologica 2012;97:1786-94. [PMID: 23065504 DOI: 10.3324/haematol.2012.072207] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
33 Heimpel H, Wilts H, Hirschmann W, Hofmann W, Siciliano R, Steinke B, Wechsler J. Aplastic Crisis as a Complication of Congenital Dyserythropoietic Anemia Type II. Acta Haematol 2007;117:115-8. [DOI: 10.1159/000097360] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
34 Khoriaty R, Everett L, Chase J, Zhu G, Hoenerhoff M, McKnight B, Vasievich MP, Zhang B, Tomberg K, Williams J, Maillard I, Ginsburg D. Pancreatic SEC23B deficiency is sufficient to explain the perinatal lethality of germline SEC23B deficiency in mice. Sci Rep 2016;6:27802. [PMID: 27297878 DOI: 10.1038/srep27802] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
35 Khoriaty R, Vasievich MP, Jones M, Everett L, Chase J, Tao J, Siemieniak D, Zhang B, Maillard I, Ginsburg D. Absence of a red blood cell phenotype in mice with hematopoietic deficiency of SEC23B. Mol Cell Biol 2014;34:3721-34. [PMID: 25071156 DOI: 10.1128/MCB.00287-14] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
36 Bianchi P, Schwarz K, Högel J, Fermo E, Vercellati C, Grosse R, van Wijk R, van Zwieten R, Barcellini W, Zanella A, Heimpel H. Analysis of a cohort of 101 CDAII patients: description of 24 new molecular variants and genotype-phenotype correlations. Br J Haematol 2016;175:696-704. [PMID: 27471141 DOI: 10.1111/bjh.14271] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
37 Khan M, Iftikhar R, Ghafoor T, Hussain F, Chaudhry QUN, Mahmood SK, Shahbaz N, Khan MA, Khattak TA, Shamshad GU, Rehman J, Ali S, Shah Z, Rafae A, Farhan M, Anwer F, Ahmed P. Allogeneic hematopoietic stem cell transplant in rare hematologic disorders: a single center experience from Pakistan. Bone Marrow Transplant 2021;56:863-72. [PMID: 33184452 DOI: 10.1038/s41409-020-01126-4] [Reference Citation Analysis]
38 Heimpel H, Schwarz K, Ebnöther M, Goede JS, Heydrich D, Kamp T, Plaumann L, Rath B, Roessler J, Schildknecht O, Schmid M, Wuillemin W, Einsiedler B, Leichtle R, Tamary H, Kohne E. Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation. Blood 2006;107:334-40. [PMID: 16141353 DOI: 10.1182/blood-2005-01-0421] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 3.7] [Reference Citation Analysis]
39 Iolascon A, Russo R, Delaunay J. Congenital dyserythropoietic anemias. Curr Opin Hematol 2011;18:146-51. [PMID: 21378561 DOI: 10.1097/MOH.0b013e32834521b0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
40 Renella R, Wood WG. The congenital dyserythropoietic anemias. Hematol Oncol Clin North Am 2009;23:283-306. [PMID: 19327584 DOI: 10.1016/j.hoc.2009.01.010] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
41 Iolascon A, Heimpel H, Wahlin A, Tamary H. Congenital dyserythropoietic anemias: molecular insights and diagnostic approach. Blood 2013;122:2162-6. [PMID: 23940284 DOI: 10.1182/blood-2013-05-468223] [Cited by in Crossref: 85] [Cited by in F6Publishing: 57] [Article Influence: 10.6] [Reference Citation Analysis]
42 Liu G, Niu S, Dong A, Cai H, Anderson GJ, Han B, Nie G. A Chinese family carrying novel mutations in SEC23B and HFE2, the genes responsible for congenital dyserythropoietic anaemia II (CDA II) and primary iron overload, respectively. Br J Haematol 2012;158:143-5. [PMID: 22428539 DOI: 10.1111/j.1365-2141.2012.09102.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
43 Khoriaty R, Vasievich MP, Ginsburg D. The COPII pathway and hematologic disease. Blood 2012;120:31-8. [PMID: 22586181 DOI: 10.1182/blood-2012-01-292086] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
44 Trompeter S, King M. Hereditary spherocytosis. Paediatrics and Child Health 2019;29:359-64. [DOI: 10.1016/j.paed.2019.05.006] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Salihoglu A, Elverdi T, Eskazan AE, Eyice D, Bavunoglu I, Ar MC, Ongoren S, Guzel E, Baslar Z, Tunckale A, Tuzuner N, Soysal T. Congenital Dyserythropoietic Anemia Type 1: Report of One Patient and Analysis of Previously Reported Patients Treated with Interferon Alpha. Indian J Hematol Blood Transfus. 2016;32:272-277. [PMID: 27408411 DOI: 10.1007/s12288-015-0600-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
46 Risinger M, Emberesh M, Kalfa TA. Rare Hereditary Hemolytic Anemias: Diagnostic Approach and Considerations in Management. Hematol Oncol Clin North Am 2019;33:373-92. [PMID: 31030808 DOI: 10.1016/j.hoc.2019.01.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
47 Kamiya T, Manabe A. Congenital dyserythropoietic anemia. Int J Hematol 2010;92:432-8. [PMID: 20820969 DOI: 10.1007/s12185-010-0667-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]